Pfizer’s New Oral Protease Inhibitor Could Possibly Treat And Prevent Covid-19 Pfizer’s announcement that they are developing an oral antiviral drug that could be used at the first sign of infection or exposure is promising news. It is clear that only a multifaceted approach utilizing vaccines, drug treatments, and public health measures will prevent infections from spreading.